NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-296-2005-0-DE-06 5-Aminoflavone Derivatives, Their Preparation And Their Use As Antibacterial , Anti-estrogenic And/or Antitumor Agent DE EP 94112509.8 Expired
NCI E-296-2005-0-IT-09 5-Aminoflavone Derivatives, Their Preparation And Their Use As Antibacterial , Anti-estrogenic And/or Antitumor Agent IT EP 94112509.8 Expired
NCI E-296-2005-0-EP-04 5-Aminoflavone Derivatives, Their Preparation And Their Use As Antibacterial , Anti-estrogenic And/or Antitumor Agent EP National Stage 94112509.8 Expired
NCI E-296-2005-0-GB-05 5-Aminoflavone Derivatives, Their Preparation And Their Use As Antibacterial , Anti-estrogenic And/or Antitumor Agent GB EP 94112509.8 Expired
NCI E-296-2005-0-ES-08 5-Aminoflavone Derivatives, Their Preparation And Their Use As Antibacterial , Anti-estrogenic And/or Antitumor Agent ES EP 94112509.8 Expired
NCI E-296-2005-0-PCT-02 5-Aminoflavone Derivatives, Their Preparation And Their Use As Antibacterial , Anti-estrogenic And/or Antitumor Agent PCT PCT PCT/JP96/00181 Expired
NIAID E-017-1996-0-US-01 CELLS EXPRESSING BOTH HUMAN CD4 AND A HUMAN FUSION ACCESSORY FACTOR ASSOCIATED WITH HIV INFECTION US 60/010,854 Abandoned
NIMH E-110-1993-0-US-10 ANTIBACTERIAL THERAPY WITH BACTERIOPHAGE GENOTYPICALLY MODIFIED TO DELAY INACTIVATION BY THE HOST DEFENSE SYSTEM US CON 08/593,269 5688501 Abandoned PDF
NIDDK E-225-1995-0-US-01 Dihydropyridine-, Pyridine-, Benzopyranone-, and Triazoloquinazoline Derivatives, Their Preparation and Their Use as Adenosine Receptor Antagonists. US 60/010,737 Abandoned
NCI E-036-1997-0-US-01 PEPTIDE ANTIGENS FOR IMMUNOTHERAPEUTIC TREATMENT AND/OR PREVENTION OF HIV US 60/010,560 Abandoned
NCI E-054-1992-1-US-02 Method For Measuring Incident Light in a Body Cavity US DIV 08/592,440 5730700 Expired PDF
NCI E-052-1995-0-PCT-02 Induction of an Activated Myeloid Dendritic Cell Phenotype PCT PCT PCT/US1996/001090 Abandoned
NEI E-199-1995-0-US-01 HYDROXYLAMINE COMPOSITIONS FOR THE PREVENTION OR RETARDATION OF CATARACTS US 60/010,637 Abandoned
NCI E-062-1995-2-JP-02 IMMUNOTOXIN-MEDIATED CONDITIONAL DISRUPTION OF SPECIFIC NEURONS IN TRANSGENIC MICE JP National Stage 08-023316 Abandoned
OD E-999-2001-0-US-01 Primate Embryonic Stem Cells US ORD 08/591,246 5843780 Expired PDF
NINDS E-106-1995-0-PCT-02 DELIVERY OF THERAPEUTIC AGENTS BY GENE THERAPY PCT PCT PCT/US96/00555 Expired
NCI E-137-1995-0-PCT-02 IMMUNOGENIC COMPOSITIONS CONTAINING RECOMBINANT ATTENUATED POXVIRUSES EXPRESSING HTLV ANTIGENS PCT PCT PCT/US1996/000547 Expired
NINDS E-106-1995-0-EP-06 DELIVERY OF THERAPEUTIC AGENTS BY GENE THERAPY EP National Stage 96904466.8 Abandoned
NINDS E-106-1995-0-JP-07 DELIVERY OF THERAPEUTIC AGENTS BY GENE THERAPY JP National Stage 08-522349 Abandoned
NINDS E-106-1995-0-AU-05 DELIVERY OF THERAPEUTIC AGENTS BY GENE THERAPY AU National Stage 48566/96 Abandoned
NCI E-057-1994-1-EP-05 P15 AND TYROSINASE MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS EP National Stage 96903473.5 Abandoned
NCI E-057-1994-1-JP-06 P15 AND TYROSINASE MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS JP National Stage 521840/96 Abandoned
NCI E-057-1994-1-AU-03 P15 AND TYROSINASE MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS AU National Stage 47554/96 Abandoned
NCI E-057-1994-1-PCT-02 No_Patent_Title PCT PCT PCT/US96/00473 Expired
NCI E-057-1994-1-CA-04 P15 AND TYROSINASE MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS CA National Stage 2209990 Abandoned
NHLBI E-156-1992-0-US-06 IMPROVED EXPRESSION OF HUMAN MULTIDRUG RESISTANCE GENES AND IMPROVED SELECTION OF CELLS TRANSDUCED WITH SUCH GENES US FWC 08/583,276 5837536 Expired PDF
NIEHS E-237-1994-9-US-01 17Q-LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILITY GENE US CIP 08/488,011 5753441 Expired PDF
NCI E-054-1995-0-PCT-02 SYSTEM AND METHOD FOR SIMULATING A TWO-MULTIDIMENSIONAL RADIATION INTENSITY DISTRIBUTION OF PHOTON OR ELECTRON BEAMS PCT PCT PCT/US96/00481 Abandoned
NCI E-149-1993-2-US-01 Compositions and Methods for Diagnosis of Mutation in the Von Hippel- Lindau Tumor Supressor Gene US ORD 08/583,289 Abandoned
NCI E-002-1996-0-US-01 MESOTHELIN, A DIFFERENTIATION ANTIGEN PRESENT ON MESOTHELIUM, MESOTHELIOMAS AND OVARIAN CANCERS AND METHODS AND KITS FOR TARGETING.. US 60/010,166 Abandoned
NIEHS E-009-1994-0-CA-06 Farnesoid Activated Receptor Polypeptides,And Ucleic Acid Encoding The Same CA National Stage 2210190 Expired
NIEHS E-009-1994-0-EP-03 A farnesoid activated receptor (FAR) and method for screening for modulators of processes mediated by the FAR EP National Stage 95943987.8 Expired
NIEHS E-009-1994-0-AU-07 Farnesoid Activated Receptor Polypeptides,And Ucleic Acid Encoding The Same AU National Stage 45303/96 Expired
NIEHS E-009-1994-0-PCT-02 Farnesoid Activated Receptor Polypeptides,And Ucleic Acid Encoding The Same PCT PCT PCT/US95/017023 Expired
NIEHS E-009-1994-0-JP-05 Farnesoid Activated Receptor Polypeptides,And Ucleic Acid Encoding The Same JP National Stage 521693/96 Expired
NCI E-157-1993-4-US-02 MIXTURES OF DDI AND D4T WITH HYDROXYCARBAMIDE FOR INHIBITING RETROVIRA L REPLICATION US DIV 08/577,322 5736526 Abandoned PDF
NCI E-220-1994-0-CA-03 2,5-DIAMINO-3,4-DISUBSTITUTED-1,6-DIPHENYLHEXANE ISOSTERES COMPRISING BENZAMIDE, SULFONAMIDE AND ANTHRANILAMIDE SUBUNITS AND METHODS OF USING SAME CA National Stage 2206787 Abandoned
NCI E-220-1994-0-FR-12 2,5-DIAMINO-3,4-DISUBSTITUTED-1,6-DIPHENYLHEXANE ISOSTERES COMPRISING BENZAMIDE, SULFONAMIDE AND ANTHRANILAMIDE SUBUNITS AND METHODS... FR EP 95942621.4 Abandoned
NCI E-220-1994-0-DE-11 2,5-DIAMINO-3,4-DISUBSTITUTED-1,6-DIPHENYLHEXANE ISOSTERES COMPRISING BENZAMIDE, SULFONAMIDE AND ANTHRANILAMIDE SUBUNITS AND METHODS... DE EP 95942621.4 Abandoned
NCI E-220-1994-0-BE-09 2,5-DIAMINO-3,4-DISUBSTITUTED-1,6-DIPHENYLHEXANE ISOSTERES COMPRISING BENZAMIDE, SULFONAMIDE AND ANTHRANILAMIDE SUBUNITS AND METHODS... BE EP 95942621.4 Abandoned
NCI E-220-1994-0-CH-10 2,5-DIAMINO-3,4-DISUBSTITUTED-1,6-DIPHENYLHEXANE ISOSTERES COMPRISING BENZAMIDE, SULFONAMIDE AND ANTHRANILAMIDE SUBUNITS AND METHODS... CH EP 95942621.4 Abandoned
NCI E-220-1994-0-IT-14 2,5-DIAMINO-3,4-DISUBSTITUTED-1,6-DIPHENYLHEXANE ISOSTERES COMPRISING BENZAMIDE, SULFONAMIDE AND ANTHRANILAMIDE SUBUNITS AND METHODS... IT EP 95942621.4 Abandoned
NCI E-220-1994-0-EP-04 2,5-DIAMINO-3,4-DISUBSTITUTED-1,6-DIPHENYLHEXANE ISOSTERES COMPRISING BENZAMIDE, SULFONAMIDE AND ANTHRANILAMIDE SUBUNITS AND METHODS OF USING SAME EP National Stage 95942621.4 Abandoned
NCI E-220-1994-0-GB-13 2,5-DIAMINO-3,4-DISUBSTITUTED-1,6-DIPHENYLHEXANE ISOSTERES COMPRISING BENZAMIDE, SULFONAMIDE AND ANTHRANILAMIDE SUBUNITS AND METHODS... GB EP 95942621.4 Abandoned
NCI E-220-1994-0-JP-06 2,5-DIAMINO-3,4-DISUBSTITUTED-1,6-DIPHENYLHEXANE ISOSTERES COMPRISING BENZAMIDE, SULFONAMIDE AND ANTHRANILAMIDE SUBUNITS AND METHODS... JP National Stage 519947/96 Abandoned
NCI E-220-1994-0-AU-05 2,5-DIAMINO-3,4-DISUBSTITUTED-1,6-DIPHENYLHEXANE ISOSTERES COMPRISING BENZAMIDE, SULFONAMIDE AND ANTHRANILAMIDE SUBUNITS AND METHODS OF USING SAME AU National Stage 43786/96 Abandoned
NCI E-220-1994-0-PCT-02 No_Patent_Title PCT PCT PCT/US95/16549 Expired
NCI E-027-1996-0-US-01 CYTOKINE ENHANCEMENT OF DNA IMMUNIZATION RESULTS IN INCREASED SPECIFIC CELLULAR AND HUMORAL IMMUNE RESPONSES AGAINST PATHOGENIC DISEASES... US ORD 08/575,072 Abandoned
NHLBI E-232-1994-0-PCT-02 No_Patent_Title PCT PCT PCT/US95/16300 Abandoned
NCI E-131-1994-0-US-02 SUBSTANTIALLY PURE NON-IL-2 T-CELL GROWTH FACTORS US DIV 08/572,423 Abandoned